KLK3 and posterior cortical atrophy: Barnett et al35 examined the cost-effectiveness of PCa screening strategies for people with PSA levels above 4 ng/mL and found that MRI and a combined biopsy in which both a standard biopsy and targeted MRI and ultrasonography fusion biopsy are performed is the optimal strategy, with an ICER of $23 483 per QALY.